$1.82
-0.06[-3.19%]
At close: Apr 24
$1.82
0[0.00%]
After Hours: 6:44PM EDT
Vor Biopharma
(NASDAQ:VOR)Latest News for Vor Biopharma Stock (NASDAQ:VOR)
Vor Biopharma Stock (NASDAQ: VOR)
Categories: All
Tuesday, April 23, 2024
Friday, April 05, 2024
Friday, March 22, 2024
Thursday, March 21, 2024
- Stifel Maintains Buy on Vor Biopharma, Lowers Price Target to $12Benzinga Newsdesk - Mar 21, 2024, 9:39AM
- Wedbush Reiterates Outperform on Vor Biopharma, Maintains $11 Price TargetBenzinga Newsdesk - Mar 21, 2024, 9:14AM
- Oppenheimer Reiterates Outperform on Vor Biopharma, Lowers Price Target to $15Benzinga Newsdesk - Mar 21, 2024, 9:02AM
- HC Wainwright & Co. Reiterates Buy on Vor Biopharma, Maintains $17.5 Price TargetBenzinga Newsdesk - Mar 21, 2024, 6:44AM
Wednesday, March 20, 2024
- Vor Biopharma: Q4 Earnings InsightsBenzinga Insights - Mar 20, 2024, 5:30PM
- Vor Biopharma Expects To Report Further Engraftment And Protection Data From The VBP101 Clinical Trial In H2 2024Benzinga Newsdesk - Mar 20, 2024, 4:34PM
- Vor Biopharma Q4 2023 GAAP EPS $(0.39) Beats $(0.51) EstimateBenzinga Newsdesk - Mar 20, 2024, 4:30PM
Thursday, January 18, 2024
Wednesday, January 17, 2024
Thursday, November 09, 2023
Tuesday, November 07, 2023
Thursday, November 02, 2023
Tuesday, October 03, 2023
Thursday, September 21, 2023
Tuesday, September 19, 2023
Monday, August 14, 2023
Friday, August 11, 2023
- Stocks That Hit 52-Week Lows On FridayBenzinga Insights - Aug 11, 2023, 2:01PM
- Wedbush Maintains Outperform on Vor Biopharma, Lowers Price Target to $11Benzinga Newsdesk - Aug 11, 2023, 10:43AM
- HC Wainwright & Co. Reiterates Buy on Vor Biopharma, Maintains $17.5 Price TargetBenzinga Newsdesk - Aug 11, 2023, 6:33AM
Thursday, August 10, 2023
Tuesday, August 08, 2023
Thursday, July 06, 2023
Wednesday, July 05, 2023
Monday, June 12, 2023
Friday, June 09, 2023
Tuesday, May 16, 2023
- Benzinga's Top Ratings Upgrades, Downgrades For May 16, 2023Benzinga Insights - May 16, 2023, 11:00AM
- HC Wainwright & Co. Reiterates Buy on Vor Biopharma, Maintains $17.5 Price TargetBenzinga Newsdesk - May 16, 2023, 6:30AM
- JonesTrading Initiates Coverage On Vor Biopharma with Buy Rating, Announces Price Target of $18Benzinga Newsdesk - May 16, 2023, 5:05AM
Friday, May 12, 2023
Thursday, May 11, 2023
Friday, March 24, 2023
- Dow Rises 50 Points; Oxford Industries Shares PlungeLisa Levin - Mar 24, 2023, 2:28PM
- Why Scholastic Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Friday's Mid-Day SessionLisa Levin - Mar 24, 2023, 1:03PM
- Where Vor Biopharma Stands With AnalystsBenzinga Insights - Mar 24, 2023, 1:01PM
- Truist Securities Maintains Buy Rating for Vor Biopharma: Here's What You Need To KnowBenzinga Insights - Mar 24, 2023, 1:00PM
- Truist Securities Maintains Buy on Vor Biopharma, Lowers Price Target to $16Benzinga Newsdesk - Mar 24, 2023, 12:29PM
- Vor Biopharma shares are trading higher after the company reported better-than-expected Q4 EPS results.Benzinga Newsdesk - Mar 24, 2023, 10:37AM
- Stifel Maintains Buy on Vor Biopharma, Lowers Price Target to $16Benzinga Newsdesk - Mar 24, 2023, 10:21AM
- Oppenheimer Reiterates Outperform on Vor Biopharma, Maintains $18 Price TargetBenzinga Newsdesk - Mar 24, 2023, 8:50AM
- JMP Securities Reiterates Market Outperform on Vor Biopharma, Maintains $12 Price TargetBenzinga Newsdesk - Mar 24, 2023, 8:08AM
- Baird Maintains Outperform on Vor Biopharma, Lowers Price Target to $22Benzinga Newsdesk - Mar 24, 2023, 6:42AM
- HC Wainwright & Co. Reiterates Buy on Vor Biopharma, Lowers Price Target to $17.5Benzinga Newsdesk - Mar 24, 2023, 6:19AM